STIMLABS LLC has a total of 12 patent applications. Its first patent ever was published in 2016. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are INST DE BIOLOGIA MOLECULAR E CELULAR IBMC, DALIM TISSEN and KOYAMA YOSHIYUKI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Basic materials chemistry | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Object sterilising | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Preservation of human bodies | |
#6 | Peptides | |
#7 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Daniel John | 12 |
#2 | Griffiths Sarah | 12 |
#3 | Berg Richard A | 9 |
#4 | Berg Richard | 2 |
#5 | Roy Annelise Mowry | 1 |
Publication | Filing date | Title |
---|---|---|
US2019192734A1 | Translucent, Dehydrated Placental Tissue and Methods of Producing and Using the Same. | |
EP3349812A1 | Compositions derived from placenta and methods of producing the same | |
AU2016324167A1 | Compositions derived from placenta and methods of producing the same | |
US2018311283A1 | Products derived from amniotic fluid and methods of use |